Global tumor ablation market is
expected to reach USD 1.5 billion by 2022, according to a new study by Grand
View Research Inc. Rising prevalence of different forms of cancer and
increasing technological advancements in the field of thermal ablation
techniques are the most prominent drivers of the market.
Besides the use of
thermal ablation, techniques such as laser ablation, irreversible
electroporation, High Intensity Focused Ultrasonography (HIFU) are also
clinically growing, concurrently propelling the tumor ablation industry.
Occurrence of lung,
breast, and liver cancer is on the rise globally. According to the Center for
Disease Control (CDC) and other organizations, currently, about 210,828 cases
of lung cancer, 2.9 million cases of breast cancer, and over 2.7 million cases
of prostate cancer are reported in the U.S. alone.
In terms of
technological advancement, companies such as SonaCare Medical are coupling
ablation techniques with other technologies to improve accuracy, performance,
and level of care. SonaLink, a remote patient monitoring platform, was put to
use along with Sonatherm ablation system to enable physicians to enhance
patient care experience, thereby promoting market growth.
The industry is also
anticipated to witness mergers and joint collaborations as a tool to curb
rising competition. For instance, Boston Scientific Corporation acquired C.R.
Bard Electrophysiology, which led to a 48.0% hike in profit for the former
company.
Browse full report by Grand View Research
:
Further key findings from the study suggest:
·
Microwave ablation technology is expected
to be the fastest growing segment over the forecast period at a CAGR of over
15.0%. Reduction in the procedure time and low cost for treatment are some of
the attributes favoring growth.
·
In terms of treatment, surgical ablation is
predicted to form the largest market by 2022 with about 35.0% share. Liver and
lung cancer ablation require surgical procedures, and since these form the
largest and fastest growing segments, they concomitantly propel surgical
ablation growth.
·
Lung cancer forms the most lucrative market
and is anticipated to be the fastest growing segment over the forecast period.
By 2022, it is expected to contribute about 15.0% of the revenue share owing to
its rising prevalence rate across the globe.
·
According to market forecast for 2022,
North America is expected to dominate the market and Asia Pacific is
anticipated to witness the fastest growth. Augmenting growth in the cancer
prevalence and rising healthcare expenditure in regions such as China, Korea,
and India are factors responsible for this rapid growth.
·
Major players of the market include
HealthTronics, Galil Medical Inc., Angiodynamics, Medtronic Plc. (Covidien),
Boston Scientific Corporation, SonaCare Medical, Misonix Inc., EDAP TMS S.A.,
and Neuwave Medical Inc. To retain market leadership, players such as Medtronic
are working towards acquiring other companies and expanding their portfolio.
For instance, in January 2016, Medtronic acquired the OsteoCool RF Ablation
System from Baylis Medical.
Browse more reports of
this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global tumor
ablation market on the basis of technology, treatment, application, and
region
Global Tumor Ablation Technology Outlook (USD million),
2012 - 2022
·
Radiofrequency
·
Microwave ablation
·
Cryoablation
·
Other ablation technologies
Global Tumor Ablation Treatment Outlook (USD million),
2012 - 2022
·
Surgical tumor ablation
·
Laparoscopic tumor ablation
·
Percutaneous tumor ablation
Global Tumor Ablation Application Outlook (USD million),
2012 - 2022
·
Liver cancer
·
Breast cancer
·
Lung cancer
·
Prostate cancer
·
Other cancers
Tumor Ablation Region Outlook (USD million), 2012 - 2022
·
North America
o U.S.
o U.S. tumor ablation market technology outlook
o Radiofrequency
o Microwave ablation
o Cryoablation
o Other ablation technologies
o U.S. tumor ablation market treatment outlook
o Surgical tumor ablation
o Laparoscopic tumor ablation
o Percutaneous
o U.S. tumor ablation market application outlook
o Liver cancer
o Breast cancer
o Lung cancer
o Prostate cancer
o Other cancer
o Canada
o Canada tumor ablation market technology outlook
o Radiofrequency
o Microwave ablation
o Cryoablation
o Other ablation technologies
o Canada tumor ablation market treatment outlook
o Surgical tumor ablation
o Laparoscopic tumor ablation
o Percutaneous
o Canada tumor ablation market application outlook
o Liver cancer
o Breast cancer
o Lung cancer
o Prostate cancer
o Other cancer
·
Europe
o UK
o UK tumor ablation market technology outlookUK tumor
ablation market treatment outlook
o Radiofrequency
o Microwave ablation
o Cryoablation
o Other ablation technologies
o Surgical tumor ablation
o Laparoscopic tumor ablation
o Percutaneous
o UK tumor ablation market application outlook
o Liver cancer
o Breast cancer
o Lung cancer
o Prostate cancer
o Other cancer
o Germany
o Germany tumor ablation market technology outlook
o Radiofrequency
o Microwave ablation
o Cryoablation
o Other ablation technologies
o Germany tumor ablation market treatment outlook
o Surgical tumor ablation
o Laparoscopic tumor ablation
o Percutaneous
o Germany tumor ablation market application outlook
o Liver cancer
o Breast cancer
o Lung cancer
o Prostate cancer
o Other cancer
·
Asia Pacific
o Japan
o Japan tumor ablation market technology outlook Japan
tumor ablation market treatment outlook
o Radiofrequency
o Microwave ablation
o Cryoablation
o Other ablation technologies
o Surgical tumor ablation
o Laparoscopic tumor ablation
o Percutaneous
o Japan tumor ablation market application outlook
o Liver cancer
o Breast cancer
o Lung cancer
o Prostate cancer
o Other cancer
o China
o China tumor ablation market technology outlook
o Radiofrequency
o Microwave ablation
o Cryoablation
o Other ablation technologies
o China tumor ablation market treatment outlook
o Surgical tumor ablation
o Laparoscopic tumor ablation
o Percutaneous
o China tumor ablation market application outlook
o Liver cancer
o Breast cancer
o Lung cancer
o Prostate cancer
o Other cancer
·
Latin America
o Brazil
o Brazil tumor ablation market technology outlook
o Radiofrequency
o Microwave ablation
o Cryoablation
o Other ablation technologies
o Brazil tumor ablation market treatment outlook
o Surgical tumor ablation
o Laparoscopic tumor ablation
o Percutaneous
o Brazil tumor ablation market application outlook
o Liver cancer
o Breast cancer
o Lung cancer
o Prostate cancer
o Other cancer
o Mexico
o Mexico tumor ablation market technology outlook
o Radiofrequency
o Microwave ablation
o Cryoablation
o Other ablation technologies
o Mexico tumor ablation market treatment outlook
o Surgical tumor ablation
o Laparoscopic tumor ablation
o Percutaneous
o Mexico tumor ablation market application outlook
o Liver cancer
o Breast cancer
o Lung cancer
o Prostate cancer
o Other cancer
·
MEA
o South Africa
o South Africa tumor ablation market technology outlook
o Radiofrequency
o Microwave ablation
o Cryoablation
o Other ablation technologies
o South Africa tumor ablation market treatment outlook
o Surgical tumor ablation
o Laparoscopic tumor ablation
o Percutaneous
o South Africa tumor ablation market application outlook
o Liver cancer
o Breast cancer
o Lung cancer
o Prostate cancer
o Other cancer
o Saudi Arabia
o Saudi Arabia tumor ablation market technology outlook
o Radiofrequency
o Microwave ablation
o Cryoablation
o Other ablation technologies
o Saudi Arabia tumor ablation market treatment outlook
o Surgical tumor ablation
o Laparoscopic tumor ablation
o Percutaneous
o Saudi Arabia tumor ablation market application outlook
o Liver cancer
o Breast cancer
o Lung cancer
o Prostate cancer
o Other cancer
View Press Release of this research
report by Grand View Research: http://www.grandviewresearch.com/press-release/global-tumor-ablation-market
About Grand View Research
Grand View
Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For More Information: www.grandviewresearch.com
